Drug Trial Radar · NCT05076149
A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation
Last checked: Nov 19, 2026Latest source record: Jun 13, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
597
Actual
Start
Oct 27, 2021
Primary completion
May 18, 2023
Study completion Nov 30, 2023
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- Oct 13, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants who are homozygous for F508del, heterozygous for F508del and a gating (F/G) or residual function (F/RF) mutation, or have at least 1 other TCR CF transmembrane conductance regulator (CFTR) gene mutation and no F508del mutation.
Conditions
- Cystic Fibrosis
Interventions
VX-121/TEZ/D-IVADrug
Fixed-dose combination tablets for oral administration.
ELX/TEZ/IVADrug
Fixed-dose combination tablets for oral administration.
IVADrug
Tablet for oral administration.
Placebo (matched to VX-121/TEZ/D-IVA)Drug
Placebo matched to VX-121/TEZ/D-IVA for oral administration.
Placebo (matched to ELX/TEZ/IVA)Drug
Placebo matched to ELX/TEZ/IVA for oral administration.
Placebo (matched to IVA)Drug
Placebo matched to IVA for oral administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute Change in Percent Predicted Forced Expiratory Volume in 1second (ppFEV1)Time frame: From Baseline Through Week 24
Locations
170 sites in 20 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Banner University of Arizona Medical Center
Tucson, Arizona
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Children's Hospital Los Angeles
Los Angeles, California
Children's Hospital of Orange County
Orange, California
University of California Davis Medical Center
Sacramento, California
Children's Hospital of Colorado
Aurora, Colorado
National Jewish Health
Denver, Colorado
Yale New Haven Hospital
New Haven, Connecticut
Nemours Children's Specialty Care
Jacksonville, Florida
University of Miami Miller School of Medicine
Miami, Florida
Central Florida Pulmonary Group, PA
Orlando, Florida
Nemours Children's Specialty Care, Pensacola
Pensacola, Florida
Johns Hopkins All Children's Hospital Outpatient Care Center
St. Petersburg, Florida
The Emory Clinic at Chantilly
Atlanta, Georgia
St. Luke's Cystic Fibrosis Center of Idaho
Boise, Idaho
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Northwestern Memorial Hospital
Chicago, Illinois
Indiana University
Indianapolis, Indiana
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana
University of Kentucky
Lexington, Kentucky
Tulane Medical Center
New Orleans, Louisiana
Maine Medical Partners
Portland, Maine
Massachusetts General Hospital Cystic Fibrosis Center Clinical Rsearch Center
Boston, Massachusetts
Boston Children's Hospital
Boston, Massachusetts
UMass Memorial Medical Center
Worcester, Massachusetts
Michigan Medicine
Ann Arbor, Michigan
Harper University Hospital
Detroit, Michigan
Spectrum Health Medical Group Adult Cystic Fibrosis Care Center
Grand Rapids, Michigan
University of Mississippi Medical Center
Jackson, Mississippi
The Children's Mercy Hospital
Kansas City, Missouri
Washington University School of Medicine
St Louis, Missouri
Billings Clinic
Billings, Montana
Morristown Medical Center
Morristown, New Jersey
CF Therapeutics Development Center of Western New York
Buffalo, New York
Northwell Health- Long Island Jewish Medical Center
New Hyde Park, New York
Columbia University Medical Center
New York, New York
SUNY Upstate Medical University
Syracuse, New York
Wake Forest Baptist Health
Winston-Salem, North Carolina
Akron Children's Hospital
Akron, Ohio
Showing 40 of 170 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.